Medications: Medicare Should Raise Prices Retroactively For Pricey Drugs, Docs Say

Why This Topic Matters

The article addresses policy and operational issues that can affect how providers are paid and how services are classified or billed under Medicare. It is useful for readers monitoring reimbursement changes, coding-related billing processes, and the impact of status determinations on payment.

Article Sections

1. Drug pricing and payment transparency concerns

   Physicians raise concerns about Medicare drug payment methodology, data availability, and whether providers can obtain medications at the payment levels being used. The discussion focuses on Medicare pricing policy and provider payment impact.

2. Oncology demonstration project billing

   The article discusses billing issues tied to a cancer care demonstration project, including concerns about secondary payors and recognition of project-specific billing identifiers. It highlights operational challenges in collecting payment for covered portions of care.

3. RVU updates

   This section covers the CMS and AMA RUC review process for existing relative value units and the types of services under review. It places the discussion in the context of changing site of service patterns.

4. Observation

   The article addresses confusion over hospital status decisions and the difference between observation and inpatient admission. It also notes the payment implications and administrative difficulties associated with these classifications.